Logo image of NUW

NUVEEN AMT-FREE MUNI VAL (NUW) Stock Overview

NYSE:NUW - US6706951059

14.03 USD
+0.09 (+0.65%)
Last: 9/8/2025, 12:20:20 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NUW. NUW was compared to 0 industry peers in the Unkown industry. NUW has a bad profitability rating. Also its financial health evaluation is rather negative. NUW has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

NUW had positive earnings in the past year.
NUW had positive earnings in 4 of the past 5 years.
In the past 5 years NUW always reported negative operating cash flow.
NUW Yearly Net Income VS EBIT VS OCF VS FCFNUW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

Industry RankSector Rank
ROA 3.01%
ROE 3.16%
ROIC 2.49%
ROA(3y)-1.46%
ROA(5y)0.61%
ROE(3y)-1.37%
ROE(5y)0.69%
ROIC(3y)2.64%
ROIC(5y)2.43%
NUW Yearly ROA, ROE, ROICNUW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

NUW's Profit Margin has been stable in the last couple of years.
In the last couple of years the Operating Margin of NUW has remained more or less at the same level.
In the last couple of years the Gross Margin of NUW has remained more or less at the same level.
Industry RankSector Rank
OM 84.12%
PM (TTM) 80.85%
GM 84.9%
OM growth 3Y1.98%
OM growth 5Y0.62%
PM growth 3Y13.77%
PM growth 5Y-0.04%
GM growth 3Y1.07%
GM growth 5Y0.1%
NUW Yearly Profit, Operating, Gross MarginsNUW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for NUW has been increased compared to 1 year ago.
The number of shares outstanding for NUW has been increased compared to 5 years ago.
Compared to 1 year ago, NUW has a worse debt to assets ratio.
NUW Yearly Shares OutstandingNUW Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
NUW Yearly Total Debt VS Total AssetsNUW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

NUW has an Altman-Z score of 10.91. This indicates that NUW is financially healthy and has little risk of bankruptcy at the moment.
NUW has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 10.91
ROIC/WACCN/A
WACCN/A
NUW Yearly LT Debt VS Equity VS FCFNUW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.16 indicates that NUW may have some problems paying its short term obligations.
A Quick Ratio of 0.16 indicates that NUW may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
NUW Yearly Current Assets VS Current LiabilitesNUW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 119.49% over the past year.
NUW shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.91% yearly.
Looking at the last year, NUW shows a small growth in Revenue. The Revenue has grown by 5.77% in the last year.
Measured over the past years, NUW shows a decrease in Revenue. The Revenue has been decreasing by -0.04% on average per year.
EPS 1Y (TTM)119.49%
EPS 3Y18.43%
EPS 5Y-2.91%
EPS Q2Q%22.08%
Revenue 1Y (TTM)5.77%
Revenue growth 3Y3.96%
Revenue growth 5Y-0.04%
Sales Q2Q%5.94%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NUW Yearly Revenue VS EstimatesNUW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.23 indicates a quite expensive valuation of NUW.
Compared to an average S&P500 Price/Earnings ratio of 27.02, NUW is valued at the same level.
Industry RankSector Rank
PE 29.23
Fwd PE N/A
NUW Price Earnings VS Forward Price EarningsNUW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NUW Per share dataNUW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

NUW has a Yearly Dividend Yield of 3.80%. Purely for dividend investing, there may be better candidates out there.
NUW's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 3.8%

5.2 History

NUW has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of NUW decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
NUW Yearly Dividends per shareNUW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
NUW Yearly Income VS Free CF VS DividendNUW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

More info and screens

NUVEEN AMT-FREE MUNI VAL

NYSE:NUW (9/8/2025, 12:20:20 PM)

14.03

+0.09 (+0.65%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners37.34%
Inst Owner Change-0.83%
Ins OwnersN/A
Ins Owner Change0%
Market Cap251.84M
Analysts0
Price TargetN/A
Short Float %0.15%
Short Ratio0.65
Dividend
Industry RankSector Rank
Dividend Yield 3.8%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years2
Div Non Decr Years2
Ex-Date08-15 2025-08-15 (0.0485)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 29.23
Fwd PE N/A
P/S 23.59
P/FCF N/A
P/OCF N/A
P/B 0.92
P/tB 0.92
EV/EBITDA N/A
EPS(TTM)0.48
EY3.42%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.59
BVpS15.21
TBVpS15.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.01%
ROE 3.16%
ROCE 3.27%
ROIC 2.49%
ROICexc 2.49%
ROICexgc 2.49%
OM 84.12%
PM (TTM) 80.85%
GM 84.9%
FCFM N/A
ROA(3y)-1.46%
ROA(5y)0.61%
ROE(3y)-1.37%
ROE(5y)0.69%
ROIC(3y)2.64%
ROIC(5y)2.43%
ROICexc(3y)2.65%
ROICexc(5y)2.44%
ROICexgc(3y)2.65%
ROICexgc(5y)2.44%
ROCE(3y)3.38%
ROCE(5y)3.11%
ROICexcg growth 3Y9.45%
ROICexcg growth 5Y-1.04%
ROICexc growth 3Y9.49%
ROICexc growth 5Y-1.01%
OM growth 3Y1.98%
OM growth 5Y0.62%
PM growth 3Y13.77%
PM growth 5Y-0.04%
GM growth 3Y1.07%
GM growth 5Y0.1%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z 10.91
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.49%
EPS 3Y18.43%
EPS 5Y-2.91%
EPS Q2Q%22.08%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.77%
Revenue growth 3Y3.96%
Revenue growth 5Y-0.04%
Sales Q2Q%5.94%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.67%
EBIT growth 3Y6.02%
EBIT growth 5Y0.58%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A